Kidney Failure: Clinical Trials

4 trials for Kidney Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 4
Phase 21Unknown 1

Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%
Placebo saline solution, Heparin, CINRYZE - Kidney Failure
Phase 1UnknownUniversity of Wisconsin, Madison722020-12-012020-10-22
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
rhC1INH, Saline Solution - Kidney Failure
Phase 1UnknownUniversity of Wisconsin, Madison202019-06-212020-12-14
Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
CD4+CD25+CD127lowFoxP3+ T regulatory cells injection, Alemtuzumab, Mycophenolate mofetil - End-Stage Renal Disease, Kidney Failure
Phase 1 / Phase 2UnknownPirogov Russian National Research Medical University302011-10-012011-11-18
Far Infrared Treatment for Kidney Diseases
Far Infrared Radiation (5μm to 20μm wavelength) - Kidney Failure
Phase 1UnknownGAAD Medical Research Institute Inc.102008-02-012009-01-05

Narrower conditions

Renal Insufficiency (4)  ·  Kidney Failure, Chronic (2)  ·  Acute Kidney Injury (1)  ·  Delayed Graft Function (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Renal Insufficiency, Chronic (2)

Interventions

Alemtuzumab (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Cyclosporine (1)  ·  Everolimus (1)  ·  Heparin (1)  ·  Kidney Transplantation (1)  ·  Mycophenolic Acid (1)  ·  SERPING1 protein, human (1)  ·  Saline Solution (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)  ·  conestat alfa (1)

Sponsors

University of Wisconsin, Madison (2)  ·  GAAD Medical Research Institute Inc. (1)  ·  Pirogov Russian National Research Medical University (1)

Countries

Canada (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Ken Nedd, M.D. (1)  ·  Kwasi Donyina, Ph.D. (1)  ·  Luis Fernandez (1)  ·  Luis Fernandez, MD (1)  ·  Michael M. Kaabak, M.D. Ph.D. (1)  ·  Svetlana N. Bykovskaia, M.D. Ph.D. (1)